T lymphocyte ontogeny in adenosine deaminase-deficient severe combined immune deficiency after treatment with polyethylene glycol-modified adenosine deaminase.

Adenosine deaminase (ADA) deficiency causes severe combined immune deficiency (SCID) by interfering with the metabolism of deoxyadenosine, which is toxic to T lymphocytes at all stages of differentiation. Enzyme replacement with polyethylene glycol-modified ADA (PEG-ADA) has been previously shown to...

תיאור מלא

מידע ביבליוגרפי

הוצא לאור ב:	J Clin Invest
Principais autores:	Weinberg, K, Hershfield, M S, Bastian, J, Kohn, D, Sender, L, Parkman, R, Lenarsky, C
פורמט:	Artigo
שפה:	Inglês
יצא לאור:	American Society for Clinical Investigation 1993
נושאים:	Research Article
גישה מקוונת:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC294890/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/8349799/ https://ncbi.nlm.nih.govhttps://doi.org/10.1172/JCI116626
תגים:	הוספת תג אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!